VMD · Insider Trading

Viemed Healthcare, Inc. Common Shares

Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Every open-market purchase and sale reported by VMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings

most recent

Open-Market Buys

code P

Sales

code S

Reporting Insiders

current holders

VMD — Recent Form 4 Transactions (latest 2026-08-19)

Filed	Insider	Role	Type	Shares	Value
2026-08-19	Sabrina Heltz	Director	MIXED	+15,029	−$33.59K
2026-08-19	Nitin Kaushal	Director	M	+18,786	—
2026-08-19	Randy E. Dobbs	Director	MIXED	+16,763	−$37.47K
2026-08-19	Timothy Smokoff	Director	MIXED	+15,029	−$33.59K
2026-06-26	William Frazier	Chief Medical Officer	MIXED	—	−$99.10K
2026-06-26	Timothy Smokoff	Director	Sell	−20,000	−$229.97K
2026-03-20	Michael Moore	President	Sell	−136,802	−$1.24M
2026-02-02	Trae Fitzgerald	Chief Financial Officer	MIXED	+7,115	−$44.46K
2026-02-02	Jerome Cambre	Vice President of Sales	MIXED	+6,264	−$39.11K
2026-02-02	Michael Moore	President	MIXED	+19,500	−$121.84K
2026-02-02	Casey Hoyt	Chief Executive Officer	MIXED	+25,882	−$203.29K
2026-02-02	William Frazier	Chief Medical Officer	MIXED	+1,532	−$11.82K
2026-02-02	William Todd Zehnder	Chief Operating Officer	MIXED	+15,474	−$151.96K
2026-02-02	Jeremy Trahan	General Counsel	MIXED	+7,835	−$48.84K
2026-01-23	William Todd Zehnder	Chief Operating Officer	MIXED	+82,473	−$326.78K
2026-01-23	Trae Fitzgerald	Chief Financial Officer	MIXED	+9,071	−$56.74K
2026-01-23	Casey Hoyt	Chief Executive Officer	MIXED	+36,032	−$194.48K
2026-01-23	Jerome Cambre	Vice President of Sales	MIXED	+7,892	−$50.61K
2026-01-23	William Frazier	Chief Medical Officer	MIXED	+2,232	−$15.12K
2026-01-23	Michael Moore	President	MIXED	+24,856	−$134.16K
2026-01-23	Jeremy Trahan	General Counsel	MIXED	+9,865	−$63.25K
2026-01-21	Michael Moore	President	MIXED	+18,391	−$112.02K
2026-01-21	William Todd Zehnder	Chief Operating Officer	MIXED	+18,389	−$112.04K
2026-01-21	William Frazier	Chief Medical Officer	A	+14,612 deriv.	—
2026-01-21	Jeremy Trahan	General Counsel	MIXED	+3,289	−$20.64K
2026-01-21	Casey Hoyt	Chief Executive Officer	MIXED	+27,950	−$162.25K
2026-01-21	Jerome Cambre	Vice President of Sales	MIXED	+5,741	−$36.03K
2026-01-21	Trae Fitzgerald	Chief Financial Officer	MIXED	+6,458	−$40.53K
2025-08-25	Jeremy Trahan	General Counsel	MIXED	+4,337	−$33.77K
2025-08-20	Sabrina Heltz	Director	M	+15,732	—
2025-08-20	Timothy Smokoff	Director	M	+15,732	—
2025-08-20	Randy E. Dobbs	Director	M	+17,784	—
2025-08-20	Nitin Kaushal	Director	M	+15,732	—
2025-08-14	Jerome Cambre	Vice President of Sales	Sell	−4,880	−$35.74K
2025-08-13	Michael Moore	President	D	−8,948	−$74.09K
2025-08-13	Michael Moore	President	Sell	−50,090	−$367.16K
2025-07-01	Nitin Kaushal	Director	MIXED	—	−$1.97K
2025-07-01	Michael Moore	President	MIXED	—	−$809.51K
2025-06-30	Nitin Kaushal	Director	MIXED	—	−$16.23K
2025-03-17	Timothy Smokoff	Director	Sell	−11,865	−$91.36K
2025-01-31	Jeremy Trahan	General Counsel	MIXED	+6,933	−$61.55K
2025-01-31	Casey Hoyt	Chief Executive Officer	MIXED	+26,218	−$222.27K
2025-01-31	Trae Fitzgerald	Chief Financial Officer	MIXED	+6,833	−$51.56K
2025-01-31	William Frazier	Chief Medical Officer	MIXED	+1,642	−$12.18K
2025-01-31	William Todd Zehnder	Chief Operating Officer	MIXED	+18,696	−$141.55K
2025-01-31	Michael Moore	President	MIXED	+18,696	−$141.55K
2025-01-31	Jerome Cambre	Vice President of Sales	MIXED	+6,037	−$45.17K
2025-01-23	Trae Fitzgerald	Chief Financial Officer	MIXED	+3,562	−$15.02K
2025-01-23	William Todd Zehnder	Chief Operating Officer	MIXED	+13,218	−$46.95K
2025-01-23	Casey Hoyt	Chief Executive Officer	MIXED	+19,661	−$69.82K

VMD — Current Insider Holders

Insider	Role	Shares Held	Value
Casey Hoyt	Chief Executive Officer	2,335,407	$21.42M
Michael Moore	President	1,880,134	$17.24M
William Todd Zehnder	Chief Operating Officer	390,309	$3.58M
Nitin Kaushal	Director	161,361	$1.48M
Randy E. Dobbs	Director	146,444	$1.34M
Trae Fitzgerald	Chief Financial Officer	108,903	$998.64K
Jerome Cambre	Vice President of Sales	106,443	$976.08K
Timothy Smokoff	Director	90,547	$830.32K
Sabrina Heltz	Director	82,520	$756.71K
William Frazier	Chief Medical Officer	73,214	$671.37K
Jeremy Trahan	General Counsel	46,492	$426.33K

VMD Insider Trading FAQ

Who are the insiders at VMD?

11 officers, directors and 10%+ beneficial owners currently report holdings in VMD via SEC Form 4.

Are VMD insiders buying or selling?

Across the 50 most recent Form 4 filings for VMD, 0 were open-market purchases (code P) and 5 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.

How current is VMD insider data?

Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent VMD filing is dated 2026-08-19.

How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the VMD quote page; the site-wide leaderboard is on the insider transactions hub.